References
- Kassa, J., Kuča, K., Cabal, J., and Paar, M. A comparison of the efficacy of new asymmetric bispyridinium oximes (K-27, K-48) with currently available oximes against tabun by in vivo methods. J. Toxicol. Environ. Health A. 69 (2006):1875–1882
- Kuča, K., Bartosova, L., Jun, D., Patocka, J., Cabal, J., Kassa, J., and Kunesova, G. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149 (2005): 75–82
- Lorke, D. E., Hasan, M. Y., Arafat, K., Kuča, K., Musilek, K., Schmitt, A., and Petroianu, G. A. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate (DFP). J. Appl. Toxicol. 28 (2008): 422–429
- Petroianu, G. A., and Kalasz, H. J. Comparison of the ability of oximes to reactivate human RBC cholinesterases inhibited by ethyl- and methyl-paraoxon. Curr. Organic Chemistry 11 (2007): 1624–1634
- Petroianu, G. A., Lorke, D. E. Pyridinium Oxime Reactivators of Cholinesterase Inhibited by Diisopropyl-Fluorophosphate (DFP): Predictive Value of In-Vitro Testing for In-Vivo Efficacy. Mini Rev. Med. Chem. 8 (2008): 1328–1342.
- Thiermann, H., Worek, F., Eyer, P. Comments on Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI 6.
- Worek, F., Thiermann, H., Szinicz, L., Eyer, P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem. Pharmacol; 1 (2004): 2237–2248